tbuckley/cabot-search huggingface dataset:
SEWAGE DISPOSAL AND WATER PROTECTION.
Journal: JAMA (1897)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Dog bite wounds
Authors: M. Callaham
Journal: JAMA (1980)

Dog bite wounds are a common problem with an infection rate only slightly higher than that for lacerations in general. Wounds may be sutured after debridement and thorough irrigation, unless they are located on the hand, where infection is common. Infection is caused by a variety of organisms. A penicillinase-resistant penicillin or cephalexin monohydrate is the drug of choice; studies suggest prophylactic antibiotic therapy may be useful, especially in high-risk wounds. (<i>JAMA</i>244:2327-2328, 1980)
Highlights
Journal: JAMA (2014)

In a multicenter randomized trial that enrolled 734 high-risk patients undergoing major gastrointestinal surgery, Pearse and colleagues compared usual care with a cardiac outputguided hemodynamic therapy algorithm to direct perioperative intravenous fluid and inotrope infusion with usual care.The authors found no difference in a composite outcome of 30-day moderate or major complications and mortality between the 2 treatment groups.In an Editorial, Bennett-Guerrero discusses hemodynamic goal-directed therapy in high-risk surgical patients.
New Names
Journal: JAMA (1966)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Improving Health Care for the Poor
Authors: Burton J. Williams
Journal: JAMA (1994)

<h3>To the Editor.</h3> —In his article on health care for the poor, Dr Ginzberg<sup>1</sup>begins with a clear account of the complex problems facing reformers. Unfortunately, by the end of the article, when he begins to suggest solutions to the problems, he completely abandons the careful reasoning with which he began. Ginzberg starts out by touching on the myriad social dilemmas—poverty, crime, violence, social dislocation—that have produced the present levels of chaos in our cities. He notes how all these factors have contributed to the collapse of the urban health care delivery system. Then in a curious reversal of his own thinking, he bases all his hopes for reform on changes in the medical system. He cites "long-term trend of abandonment and avoidance by physicians" of urban areas as if this was a cause rather than an effect. He calls for physician relocation as part of his solution. Where
Diastole
Authors: George N. Braman
Journal: Annals of Internal Medicine (1999)

Ad Libitum16 November 1999DiastoleGeorge N. Braman, MDGeorge N. Braman, MDBronx, NY 10471 (Braman)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-131-10-199911160-00013 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail How goodly are thy tents, O Jacob,Thy dwelling places, O Israel.Numbers 24:5Jacob was old now, crippled and half blind,Groping shadows, seeing less before himThan in tunneled dreams, what he left behind.His fair Rachel, in vision or by whimShe appears before him now, in beautyAnd youth, as when she was seen at the well—Grasped his heart at first meeting, in dutyAnd truth, an angel who had cast her spell.... Author, Article, and Disclosure InformationAffiliations: Bronx, NY 10471 (Braman)Corresponding Author: George N. Braman, MD, 6142 Delafield Avenue, Bronx, NY 10471. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 16 November 1999Volume 131, Issue 10Page: 785KeywordsAdolescentsDiastoleHeartMemoryVision ePublished: 15 August 2000 Issue Published: 16 November 1999 Copyright & PermissionsCopyright © 1999 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Prostatic Hypertrophy.
Authors: Hal. C. Wyman.
Journal: JAMA (1893)

<h3>To the Editor:</h3> —I have read the editorial on "Prostatic Hypertrophy" and desire to indicate my pleasure in reading it. Paper surgery of that sort does much good. It puts us to thinking. How many have gone down under prostatic hypertrophy and its sequelæ who might have been saved had the remedial powers of surgery with the knife been invoked. Time has been wasted in the study of catheter fever and quibbling as to the nature of the growth. Sir Andrew Clark would have conferred a blessing on<i>male</i>kind ten years ago if instead of his learned disquisition on "catheter fever and its causes," he had referred the patient to a surgeon. There is need, however, for more aggressive work on the prostate. It must be attacked earlier. A dissection of the perineal and external aspects of the prostate without opening the urethra does good if applied before the
Corrigendum
Journal: British Journal of Dermatology (2020)

In the article by Tovar-Garza et al 1 , there is an error in the second paragraph.The text:Patients who had received oral minipulse dexamethasone 4 mg on two consecutive days per week, narrowband ultraviolet B (NB-UVB), and clobetasol cream 0Á05% four times daily. . . should have beenPatients who had received oral minipulse dexamethasone 4 mg on two consecutive days per week, narrowband ultraviolet B (NB-UVB), and clobetasol cream 0Á05% once a day. . .The publisher apologizes for the error.
Intracutaneous immune serum globulin therapy in allergic children
Authors: B. C. Hilman
Journal: JAMA (1969)

Fifty allergic children with perennial bronchial asthma, aged 14 months to 13 1/2 years, from three separate pediatric allergy clinics were studied by double-blind, single crossover design comparing minute amounts (0.1 ml) of serum immune globulin given intracutaneously with placebo (sterile physiological saline). The immune serum globulin used in the study was of the same lot number and of placental origin. Random permutation tables were used to assign patients to the treatment groups. The clinical responses to immune serum globulin were excellent in 3, good in 15, fair in 20, and poor in 12. The responses to placebo were excellent in 4, good in 17, fair in 19, and poor in 10. It was concluded that there was no significant difference in the effects of immune serum globulin over those of placebo in the management of children with allergy in this study group.
Erratum
Authors: Ingrid Agartz, Martin Ingvar, Töres Theorell, Dietmar Winkler, Edda Pjrek, Jochen Kindler, Angela Heiden, Siegfried Kasper, Helen Lazaratou, Dimitris C. Anagnostopoulos, Maria Vlassopoulos, Chara Tzavara, George Zelios, Reza Emdad, Hans Peter Söndergaard, Tomas Björklund, Renato Pasquali, David Bonekamp, Heather L. Urry, Daniel Muller, Melissa A. Rosenkranz, Elliot M. Friedman, Richard J. Davidson, Burton Singer, S. Saarijärvi, J.K. Salminen, T. Toikka, Claire Daban, Anabel Martinez-Aran, Carla Torrent, Rafael Tabarés-Seisdedos, Vicent Balanzá-Martínez, Jose Salazar-Fraile, Gabriel Selva-Vera, Eduard Vieta, Carol D. Ryff, Gayle Dienberg Love, Hui-Xin Wang, Murray A. Mittleman, Constanze Leineweber, Kristina Orth-Gomer
Journal: Psychotherapy and Psychosomatics (2006)
Section 10.—Polymyositis and Dermatomyositis
Journal: JAMA (1973)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Studies of Variation in Oncogenicity of Polyoma Virus Related to Differences in Cell Culture Media
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Efficacy and Feasibility of Sorafenib As a Maintenance Agent after Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Mutated Acute Myeloid Leukemia
Authors: Giorgia Battipaglia, Annalisa Ruggeri, Matthieu Jestin, Radwan Massoud, Jean El Cheikh, Ahmad Antar, Syed Osman Ahmed, Walid Rasheed, Ramdane Belhocine, Eolia Brissot, Remy Dulery, Sandra Eder, Federica Giannotti, Francoise Isnard, Simona Lapusan, Marie-Thérèse Rubio, Anne Vekhoff, Mahmoud Aljurf, Ollivier Legrand, Mohamad Mohty, Ali Bazarbachi
Journal: Blood (2016)
Dose-dense chemotherapy with modified TCF regimen (TCF-DD) in metastatic gastric cancer (MGC): A feasibility study
Authors: M. Dalla Chiesa, G. Tomasello, S. Buti, F. Negri, M. Buononato, S. Lazzarelli, M. Brighenti, G. Donati, M. Cattaneo, R. Passalacqua
Journal: Journal of Clinical Oncology (2006)

14117 Background: Previous studies reported that in early breast cancer, lymphomas and bladder, dose-dense chemotherapy is more effective than conventional treatments. In MGC chemotherapy with Docetaxel, Cisplatin and 5-FU (TCF) q3w is very active. Based on these studies, we tested for the first time the feasibility and activity of an intensified dose-dense TCF regimen (q2w) modifying the 5-FU continuous infusion with Folinic Acid/5-FU, according to the “De Gramont regimen.” Methods: patients (pts) with histologically confirmed measurable MGC, ECOG PS 0–3 received up to six cycles of Docetaxel 85 mg/m2 day (d) 1, Cisplatin 75 mg/m2 d 1, L-Folinic Acid 100 mg/m2 d 1 and 2, followed by 5-FU 400 mg/m 2 bolus d 1 and 2 and then 600 mg/m 2 as a 22-hour continuous infusion d 1 and 2, every 14 days, plus Granulocyte-Colony Stimulating Factor 5 μg/kg/d, from day 4 to 10 of each cycle or pegfilgrastim 6 mg on day 3. Pts with a PS &gt; 1 and/or age &gt; 65 years and/or pre-treated for the advanced disease, received the same schedule with a dose reduction by 30%. Results: 16 consecutive pts were enrolled (81% male, 19% female; median age: 60, range 40–79; median ECOG PS:1, range 0–3). Two pts received previously chemotherapy for the advanced disease. A median of 4 cycles (range 1–6) per patient were administered. Eleven pts were evaluated for response (3 too early, 2 early deaths) and 13 for toxicity; 1 CR (multiple liver metastases), 6 PR, 2 SD and 2 PD were observed, for an overall disease control rate, by intention to treat, of 69% (95% CI 44–95). No treatment delays were observed in 5 pts (PS 0–1, &lt; 65 years old and all but one chemo-naïve); 8 pts did not respect the schedule (4 had PS &gt;1, two of whom were &gt; 65 years old; 4 were &gt; 65 years old with PS 0–1). Grade 3/4 neutropenia (all not febrile), thrombocytopenia, and anemia occurred in 61%, 23% and 0% of pts, respectively. Grade 3/4 nausea/vomiting occurred in 15%. Conclusion: A dose-dense TCF regimen in MGC is feasible and active and deserves to be tested in randomised studies. No significant financial relationships to disclose.
Isolation of Adenovirus Type 1 from Malignant Cervical Lymph Node
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Tic Douloureux
Authors: D. M. Zausmer
Journal: BMJ (1953)

<i>Background:</i> The current test for gestational diabetes mellitus (GDM) uses a glucose monomer test beverage, which frequently causes gastrointestinal symptoms, and venipuncture. We investigated a simplified test using a beverage of glucose polymer and a capillary whole blood glucose measurement. <i>Methods:</i> In a randomized, double-blind clinical trial, women at 24 to 28 weeks’ gestation received a 50-g glucose monomer (n = 41) or glucose polymer (n = 35) beverage. Venous and capillary blood samples were obtained 1 hour later. The women then completed standardized questionnaires about their symptoms. <i>Results:</i> The glucose polymer beverage was associated with significantly fewer symptoms than was the glucose monomer drink: the mean was 1.1 symptoms per test with the glucose monomer drink and 0.4 symptoms per test with the glucose polymer drink (<i>P</i> &lt; 0.05), 51 percent of the women developed symptoms after drinking the glucose monomer beverage, and 27 percent of the women developed symptoms after drinking the glucose polymer beverage (<i>P</i> &lt; 0.05). Glucose type did not affect the 1-hour plasma glucose level, mean 5.94 mmol/L (107 mg/dL) for the glucose monomer and 5.76 mmol/L (103.8 mg/dL) for the glucose polymer (<i>P</i> = 0.79). For the capillary test, sensitivity was 0.75 and specificity was 0.82 in detecting a screening test positive by the venous plasma glucose criterion. <i>Conclusion:</i> The results of this study indicate that a glucose polymer beverage is better tolerated than a glucose monomer beverage during GDM screening, but capillary glucose measurement might be of limited use in clinics where many personnel perform the capillary blood glucose testing.
Biliary sludge: Curiosity or culprit?
Authors: S Lee
Journal: Hepatology (1994)

Biliary Sludge: Curiosity or Culprit?With the advent and increasing popularity of abdominal ultrasonography, there is a corresponding increase in the observation of biliary sludge.There is much debate on the clinical relevance of this "new" disease entity.Some even doubt the existence of such a diagnostic label (1).Is it therefore a mere curiosity that is incidentally discovered by high-technology medicine?Or is it a culprit that occultly creates havoc and foreshadows the formation of stones?Like many areas in medicine, there is a large gray area between "totally innocent" and "invariably pathological."Although biliary sludge has been observed in a wide range of clinical disorders, few studies have vigorously examined its clinical evolution.In this issue of HEPATOLOGY, Janowitz et al. (2) retrospectively identified a population of patients with gallbladder sludge by means of ultrasonography and followed these patients' clinical courses.In most patients, sludge disappeared (71.4%), but gallstones developed in 12.5% and 7.1% had complications.As has been previously shown (3, 4), the authors suggested that the finding of biliary sludge is not entirely benign.This body of data is timely and an important contribution to the understanding of the clinical relevance of sludge.However, like any study involving gallbladder sludge, Janowitz et al. had to grapple with several poorly defined variables surrounding the subject matter.Their findings highlighted some of the frustration and fascination that occur when one tries to track the course of this disorder.Definition.The first problem in understanding biliary sludge is its definition.Bile, as secreted by the liver, is a clear, golden-brown liquid.When the solutes in bile precipitate out of solution, the mixture of particulate matter and bile is referred to as biliary sludge.This viscous suspension of precipitate is also called by other names: biliary sediments, microcrystalline disease, pseudolithiasis, microlithiasis and reversible cholelithiasis.The distinction between tiny fragments of sludge and a "big piece" of concretion ke., stone) can be difficult at times.We have suggested some features that can help to differentiate precipitations from concretions.Macroscopically, a stone is a concretion more than 2 mm in diameter that cannot be crushed by means of digital compression.This is not merely a matter of semantics.Without an accepted definition, no two studies will ever
Aluminum and Dialysis Dementia
Authors: G. M. BERLYNE
Journal: Annals of Internal Medicine (1980)

Letters1 February 1980Aluminum and Dialysis DementiaG. M. BERLYNE, M.D.G. M. BERLYNE, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-92-2-263_3 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: Dr. Arieffs comments on my letter (Annals of Internal Medicine, September 1979, p. 496) repeat his misleading misinterpretation of two lines in my paper (1), which, he declares, describe the picture of aspiration pneumonia. They read: "The lungs showed a histological appearance of patchy pneumonia with desquamation of bronchial epithelium" (1).This is not the picture of aspiration pneumonia, which has the following characteristics (2): the presence of foreign bodies; necrosis and putrefaction of lung; infiltration of polymorphs, lymphocytes, macrophages, giant cells. This histologic picture was not present, and Arieff and Schmidt's statement (3) that these rats...References1. BERLYNEBEN ARIKNOPFYAGILWEINBERGERDANOVITCH GJERGG. Aluminum toxicity in rats. Lancet. 1972 1:564-7. CrossrefMedlineGoogle Scholar2. SPENCERLIEBOW HA. Pathology of the Lungs. Vol. 1. New York: Pergamon Press; 1977. Google Scholar3. ARIEFFSCHMIDT AR. Fluid and electrolyte disorders and the central nervous system. In: MAXWELL MH, KLEEMAN CR, eds. Clinical Disorders of Fluid Electrolyte Metabolism. 3rd ed. New York: McGraw-Hill Book Co.; 1979. Google Scholar4. SEARSEALES WL. Aluminum-induced porphyria in rats. IRCS. 1973;30:35-6. Google Scholar5-16. Can be obtained from Dr. G. M. Berlyne. They have not been listed here due to editorial limitations on the number of references in letters. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: G. M. BERLYNE, M.D.Affiliations: Nephrology Section Downstate Medical Center State University of New York Brooklyn, NY 11209 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 February 1980Volume 92, Issue 2_Part_1Page: 263-264KeywordsDementiaDesquamationEpitheliumGiant cellsLungsLymphocytesMedical dialysisNecrosisPneumonia ePublished: 1 December 2008 Issue Published: 1 February 1980 PDF downloadLoading ...
Serratia granuloma
Authors: E. Epstein
Journal: JAMA (1973)

<i>A granuloma developed in the skin of the knee of a 14-year-old boy following a scratch. The lesion persisted for five years. Bacteriologic studies identified the causative organism as</i>Serratia marcescens.<i>Prompt cure was obtained by the oral use of minocycline hydrochloride.</i>